Adverse differences in cardiometabolic risk factor levels between individuals with pre-diabetes and normal glucose metabolism are more pronounced in women than in men: the Maastricht Study
Year: 2019
Type: article
Study design: Observational Study
Abstract: Objective: To investigate whether adverse differences in levels of cardiovascular risk factors in women than men, already established when comparing individuals with and without diabetes, are also present before type 2 diabetes onset. Research design and methods: In a population-based cohort study of individuals aged 40-75 years (n=3410; 49% women, 29% type 2 diabetes (oversampled by design)), we estimated associations with cardiometabolic and lifestyle risk factors of (1) pre-diabetes and type 2 diabetes (reference category: normal glucose metabolism) and (2) among non-diabetic individuals, of continuous levels of hemoglobin A1c (HbA1c). Age-adjusted sex differences were analyzed using linear and logistic regression models with sex interaction terms. Results: In pre-diabetes, adverse differences in cardiometabolic risk factors were greater in women than men for systolic blood pressure (difference, 3.02 mm Hg; 95% CI:-0.26 to 6.30), high-density lipoprotein (HDL) cholesterol (difference, -0.10 mmol/L; 95% CI: -0.18 to -0.02), total-to-HDL cholesterol ratio (difference, 0.22; 95% CI: -0.01 to 0.44), triglycerides (ratio: 1.11; 95% CI: 1.01 to 1.22), and inflammation markers Z-score (ratio: 1.18; 95% CI: 0.98 to 1.41). In type 2 diabetes, these sex differences were similar in direction, and of greater magnitude. Additionally, HbA1c among non-diabetic individuals was more strongly associated with several cardiometabolic risk factors in women than men: per one per cent point increase, systolic blood pressure (difference, 3.58 mm Hg; 95% CI: -0.03 to 7.19), diastolic blood pressure (difference, 2.10 mm Hg; 95% CI: -0.02 to 4.23), HDL cholesterol (difference, -0.09 mmol/L; 95% CI: -0.19 to 0.00), and low-density lipoprotein cholesterol (difference, 0.26 mmol/L; 95% CI: 0.05 to 0.47). With regard to lifestyle risk factors, no consistent pattern was observed. Conclusion: Our results are consistent with the concept that the more adverse changes in cardiometabolic risk factors in women (than men) arise as a continuous process before the onset of type 2 diabetes.
Institutions: Maastricht University Medical Centre, Maastricht University, Adelante, Care and Public Health Research Institute, University Medical Center Utrecht, Leiden University Medical Center, Johns Hopkins University, The George Institute for Global Health, UNSW Sydney, University of Oxford, The George Institute for Global Health
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: diabetes mellitus, prediabetes, sex differences, cardiometabolic risk factors, type 2 diabetes, HbA1c, systolic blood pressure, HDL cholesterol, triglycerides, inflammatory markers, cardiovascular risk, Maastricht Study, women's health, lifestyle risk factors, dyslipidemia, hypertriglyceridemia, hyperinflammation, hypercoagulability
Open Access status: gold
Estimated APC paid: $3,000
Funders: Sanofi, Health Foundation Limburg, ZonMw, Novo Nordisk, Stichting De Weijerhorst, Medical Research Council, European Regional Development Fund, CARIM School for Cardiovascular Diseases, Universiteit Maastricht, Care and Public Health Research Institute, Universiteit Maastricht, NUTRIM School of Nutrition and Translational Research in Metabolism, Cilag, Provincie Limburg, Janssen Nederland
OpenAlex ID: W2983007116
